A citation-based method for searching scientific literature

Maja T Tomicic, Franziska Krämer, Alexandra Nguyen, Christian Schwarzenbach, Markus Christmann. Cancers (Basel) 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A new model for prediction of drug distribution in tumor and normal tissues: pharmacokinetics of temozolomide in glioma patients.
Lula Rosso, Cathryn S Brock, James M Gallo, Azeem Saleem, Patricia M Price, Federico E Turkheimer, Eric O Aboagye. Cancer Res 2009
99
100

Targeting anticancer drug-induced senescence in glioblastoma therapy.
Maja T Tomicic, Markus Christmann. Oncotarget 2018
3
100

The Achilles' heel of senescent cells: from transcriptome to senolytic drugs.
Yi Zhu, Tamara Tchkonia, Tamar Pirtskhalava, Adam C Gower, Husheng Ding, Nino Giorgadze, Allyson K Palmer, Yuji Ikeno, Gene B Hubbard, Marc Lenburg,[...]. Aging Cell 2015
704
100

DNA topoisomerase inhibitors induce reversible senescence in normal human fibroblasts.
E Michishita, K Nakabayashi, H Ogino, T Suzuki, M Fujii, D Ayusawa. Biochem Biophys Res Commun 1998
45
100

Epithelial-mesenchymal transition induced by senescent fibroblasts.
Remi-Martin Laberge, Pierre Awad, Judith Campisi, Pierre-Yves Desprez. Cancer Microenviron 2012
129
100

Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies.
L A Hammond, J R Eckardt, S D Baker, S G Eckhardt, M Dugan, K Forral, P Reidenberg, P Statkevich, G R Weiss, D A Rinaldi,[...]. J Clin Oncol 1999
104
100

Survival and death strategies in glioma cells: autophagy, senescence and apoptosis triggered by a single type of temozolomide-induced DNA damage.
Anna V Knizhnik, Wynand P Roos, Teodora Nikolova, Steve Quiros, Karl-Heinz Tomaszowski, Markus Christmann, Bernd Kaina. PLoS One 2013
154
100

DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity.
Nicolas Malaquin, Arthur Vancayseele, Sophie Gilbert, Laureen Antenor-Habazac, Marc-Alexandre Olivier, Zakia Ait Ali Brahem, Fred Saad, Guila Delouya, Francis Rodier. Cells 2020
5
100

The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response.
Quintino Giorgio D'Alessandris, Mauro Biffoni, Maurizio Martini, Daniele Runci, Mariachiara Buccarelli, Tonia Cenci, Michele Signore, Louis Stancato, Alessandro Olivi, Ruggero De Maria,[...]. Neuro Oncol 2017
29
100

Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation.
Simona Parrinello, Jean-Philippe Coppe, Ana Krtolica, Judith Campisi. J Cell Sci 2005
385
100

DNA repair in resistance to alkylating anticancer drugs.
B Kaina, M Christmann. Int J Clin Pharmacol Ther 2002
77
100

Senescent cells and their secretory phenotype as targets for cancer therapy.
Michael C Velarde, Marco Demaria, Judith Campisi. Interdiscip Top Gerontol 2013
72
100

Abnormal mitosis triggers p53-dependent cell cycle arrest in human tetraploid cells.
Christian Kuffer, Anastasia Yurievna Kuznetsova, Zuzana Storchová. Chromosoma 2013
40
100

Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry.
Julien Sage, Abigail L Miller, Pedro A Pérez-Mancera, Julianne M Wysocki, Tyler Jacks. Nature 2003
411
100

Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma.
Yong Yu, Kolja Schleich, Bin Yue, Sujuan Ji, Philipp Lohneis, Kristel Kemper, Mark R Silvis, Nouar Qutob, Ellen van Rooijen, Melanie Werner-Klein,[...]. Cancer Cell 2018
47
100

In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells.
C Leikam, A L Hufnagel, C Otto, D J Murphy, B Mühling, S Kneitz, I Nanda, M Schmid, T U Wagner, S Haferkamp,[...]. Cell Death Dis 2015
44
100


Unexpected pieces to the senescence puzzle.
Karen Cichowski, William C Hahn. Cell 2008
61
100



Molecular Dosimetry of Temozolomide: Quantification of Critical Lesions, Correlation to Cell Death Responses, and Threshold Doses.
Björn Stratenwerth, Susanne M Geisen, Yang He, Lea Beltzig, Shana J Sturla, Bernd Kaina. Mol Cancer Ther 2021
1
100

Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging.
A Krtolica, S Parrinello, S Lockett, P Y Desprez, J Campisi. Proc Natl Acad Sci U S A 2001
986
100


The effect of an adenosine A2A agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma.
Sadhana Jackson, Jon Weingart, Edjah K Nduom, Thura T Harfi, Richard T George, Dorothea McAreavey, Xiaobu Ye, Nicole M Anders, Cody Peer, William D Figg,[...]. Fluids Barriers CNS 2018
25
100


Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.
Jean-Philippe Coppé, Christopher K Patil, Francis Rodier, Yu Sun, Denise P Muñoz, Joshua Goldstein, Peter S Nelson, Pierre-Yves Desprez, Judith Campisi. PLoS Biol 2008
100

Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
Markus Christmann, Kathrin Diesler, Dragomira Majhen, Christian Steigerwald, Nancy Berte, Halima Freund, Nikolina Stojanović, Bernd Kaina, Maja Osmak, Andreja Ambriović-Ristov,[...]. Oncotarget 2017
22
100


Functional mismatch repair and inactive p53 drive sensitization of colorectal cancer cells to irinotecan via the IAP antagonist BV6.
Maja T Tomicic, Christian Steigerwald, Birgit Rasenberger, Anamaria Brozovic, Markus Christmann. Arch Toxicol 2019
8
100

Emerging senolytic agents derived from natural products.
Wen Li, Lin Qin, Rennan Feng, Guangrong Hu, Hui Sun, Yonghan He, Rongping Zhang. Mech Ageing Dev 2019
14
100

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
Roger Stupp, Monika E Hegi, Warren P Mason, Martin J van den Bent, Martin J B Taphoorn, Robert C Janzer, Samuel K Ludwin, Anouk Allgeier, Barbara Fisher, Karl Belanger,[...]. Lancet Oncol 2009
100

Immortalized epithelial cells derived from human colon biopsies express stem cell markers and differentiate in vitro.
Andres I Roig, Ugur Eskiocak, Suzie K Hight, Sang Bum Kim, Oliver Delgado, Rhonda F Souza, Stuart J Spechler, Woodring E Wright, Jerry W Shay. Gastroenterology 2010
114
100

Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo.
Florence Debacq-Chainiaux, Jorge D Erusalimsky, Judith Campisi, Olivier Toussaint. Nat Protoc 2009
767
100

Cellular Senescence: A Translational Perspective.
James L Kirkland, Tamara Tchkonia. EBioMedicine 2017
316
100

Polyploidy: the link between senescence and cancer.
G Mosieniak, E Sikora. Curr Pharm Des 2010
56
100

Localization matters: nuclear-trapped Survivin sensitizes glioblastoma cells to temozolomide by elevating cellular senescence and impairing homologous recombination.
Thomas R Reich, Christian Schwarzenbach, Juliana Brandstetter Vilar, Sven Unger, Fabian Mühlhäusler, Teodora Nikolova, Alicia Poplawski, H Irem Baymaz, Petra Beli, Markus Christmann,[...]. Cell Mol Life Sci 2021
1
100

The Clinical Potential of Senolytic Drugs.
James L Kirkland, Tamara Tchkonia, Yi Zhu, Laura J Niedernhofer, Paul D Robbins. J Am Geriatr Soc 2017
221
100


Reversal of human cellular senescence: roles of the p53 and p16 pathways.
Christian M Beauséjour, Ana Krtolica, Francesco Galimi, Masashi Narita, Scott W Lowe, Paul Yaswen, Judith Campisi. EMBO J 2003
827
100


BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.
Dapeng Wang, Anders Berglund, Rajappa S Kenchappa, Peter A Forsyth, James J Mulé, Arnold B Etame. Sci Rep 2016
43
100

Temozolomide and Other Alkylating Agents in Glioblastoma Therapy.
Hannah Strobel, Tim Baisch, Rahel Fitzel, Katharina Schilberg, Markus D Siegelin, Georg Karpel-Massler, Klaus-Michael Debatin, Mike-Andrew Westhoff. Biomedicines 2019
44
100

7
100

Senolytic drugs: from discovery to translation.
J L Kirkland, T Tchkonia. J Intern Med 2020
64
100

Malignant gliomas in adults.
Patrick Y Wen, Santosh Kesari. N Engl J Med 2008
100

Senescence-associated reprogramming promotes cancer stemness.
Maja Milanovic, Dorothy N Y Fan, Dimitri Belenki, J Henry M Däbritz, Zhen Zhao, Yong Yu, Jan R Dörr, Lora Dimitrova, Dido Lenze, Ines A Monteiro Barbosa,[...]. Nature 2018
288
100

Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR-CHK1, p21, and NF-κB.
Dorthe Aasland, Laura Götzinger, Laura Hauck, Nancy Berte, Jessica Meyer, Melanie Effenberger, Simon Schneider, Emelie E Reuber, Wynand P Roos, Maja T Tomicic,[...]. Cancer Res 2019
51
100

Living on a break: cellular senescence as a DNA-damage response.
Fabrizio d'Adda di Fagagna. Nat Rev Cancer 2008
582
100

The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms.
Claes Bavik, Ilsa Coleman, James P Dean, Beatrice Knudsen, Steven Plymate, Peter S Nelson. Cancer Res 2006
284
100



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.